Work

AMN107, a novel aminopyrimidine inhibitor of Bcr-Abl, has significant activity in imatinib-resistant bcr-abl positive chronic myeloid leukemia (CML)

Year: 2005

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2005.23.16_suppl.3014

Authors: H. Kantarjian, O. Ottmann, J. Cortes, B. Wassmann, D. Jones, A. Hochhaus, L. Alland, M. Dugan, M. Albitar, F. Giles

Institution: Heidelberg University

Language: English

Topic: Chronic Myeloid Leukemia Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2589944677

Cites:

Cited by: 27

Related to: 10